title: Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
authors.affiliation: Department of Pathology, Faculty of Medicine, Hebrew University-Hadassah Medical School, POB 12272, 91120 Jerusalem, Israel.
authors.forename: Aliza
authors.initials: A
authors.lastname: Biton
authors.forename: Ute
authors.initials: U
authors.lastname: Bank
authors.forename: Michael
authors.initials: M
authors.lastname: Täger
authors.forename: Siegfried
authors.initials: S
authors.lastname: Ansorge
authors.forename: Dirk
authors.initials: D
authors.lastname: Reinhold
authors.forename: Uwe
authors.initials: U
authors.lastname: Lendeckel
authors.forename: Stefan
authors.initials: S
authors.lastname: Brocke
mesh_terms: D000818:Animals; D018826:CD13 Antigens / Q000378:metabolism*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D015842:Serine Proteinase Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D015842:Serine Proteinase Inhibitors; D018826:CD13 Antigens; D018819:Dipeptidyl Peptidase 4